Business
Press Release Jan 21 2026
Lupin Limited has informed the Exchange regarding a press release dated January 21, 2026, titled Lupin and Galenicum Sign License and Supply Agreement for Semaglutide in 23 Countries.
About this update from Lupin Limited
[{"type":"text","content":" Lupin Limited has informed the Exchange regarding a press release dated January 21, 2026, titled Lupin and Galenicum Sign License and Supply Agreement for Semaglutide in 23 Countries. View Attachment","length":348,"tagName":"div"}]